Central Europe a hotspot for drug trials
Leading CRO says it has seen a marked increase in the number of trials it has been asked to work on in Central Europe, and believes the trend is set to continue.
Leading CRO says it has seen a marked increase in the number of trials it has been asked to work on in Central Europe, and believes the trend is set to continue.
IBM has introduced its new InsightLink software, an application to help pharma companies create searchable online databases that will enable more sharing of research knowledge.
Alex Matter is to direct the Novartis Institute for Tropical Diseases (NITD) in Singapore after his retirement as Novartis oncology chief later ths month.
An oligonucleotide-based drug that may represent a new treatment option for multiple sclerosis has started Phase I trials in the UK.
Aventis has licensed a drug for Alzheimer's disease and other forms of dementia from Japan's Dainippon; AC-3933 is claimed to have a completely novel mechanism of action.